Intravenous vs intramuscular oxytocin: Severe PPH (≥ 1000 mL)
Intravenous showed no clear difference in severe PPH ≥ 1000 mL compared with intramuscular oxytocin (moderate certainty).
What each review found
Include earlier review versions| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Intravenous vs intramuscular oxytocin Severe PPH ≥ 1000 mL · women in the 3rd stage of labour undergoing a vaginal birth. Intravenous showed no clear difference in severe PPH ≥ 1000 mL compared with intramuscular oxytocin (moderate certainty). Intravenous versus intramuscular prophylactic oxytocin for reducing blood loss in the third stage of labour (2020) · Cochrane Headline outcomes only | RR 0.65 [0.39, 1.08] | 4 studies · 6681 participants | Moderate |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Intravenous versus intramuscular prophylactic oxytocin for reducing blood loss in the third stage of labour 2020 · Cochrane Headline outcomes only | Not reported | list not extracted yet | Not assessed |
Studies behind the findings
None of these reviews ties its included studies to this outcome in the data here. Cochrane reviews and reviews with headline outcomes only do not list their studies yet.
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.